{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:22:01Z","timestamp":1790914921461,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y2020948"],"award-info":[{"award-number":["Y2020948"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101571","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T17:43:28Z","timestamp":1726163008000},"page":"101571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of prophylactic antibiotics in the adjuvant treatment of alcohol-related liver disease (ALD): A systematic review and meta-analysisProphylactic antibiotics in ALD"],"prefix":"10.1016","volume":"30","author":[{"given":"Xiuyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aohep.2024.101571_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101162","article-title":"Alcohol-associated liver disease: epidemiology and management","volume":"29","author":"Hern\u00e1ndez-\u00c9vole","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2024.101571_bib0002","article-title":"Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy","volume":"14","author":"Shi","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101571_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cld.2018.09.005","article-title":"Acute alcoholic hepatitis","volume":"23","author":"Im","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.aohep.2024.101571_bib0004","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"29","key":"10.1016\/j.aohep.2024.101571_bib0005","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.3748\/wjg.v22.i29.6673","article-title":"Microbiota-based treatments in alcoholic liver disease","volume":"22","author":"Sung","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101571_bib0006","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5009\/gnl16477","article-title":"Pathophysiology and management of alcoholic liver disease: update 2016","volume":"11","author":"Stickel","year":"2017","journal-title":"Gut Liver"},{"issue":"3","key":"10.1016\/j.aohep.2024.101571_bib0007","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2011.02650.x","article-title":"Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia","volume":"32","author":"Kalambokis","year":"2012","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.aohep.2024.101571_bib0008","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/liv.15207","article-title":"Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: a pilot study (RIFA-AH)","volume":"42","author":"Jim\u00e9nez","year":"2022","journal-title":"Liver Int"},{"issue":"18","key":"10.1016\/j.aohep.2024.101571_bib0009","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/jama.2023.4902","article-title":"Effect of prophylactic antibiotics on mortality in severe alcohol-related hepatitis: a randomized clinical trial","volume":"329","author":"Louvet","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.aohep.2024.101571_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101571_bib0011","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"10","key":"10.1016\/j.aohep.2024.101571_bib0012","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.aohep.2024.101571_bib0013","first-page":"1","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","volume":"2","author":"Peterson","year":"2011","journal-title":"OHRI"},{"issue":"11","key":"10.1016\/j.aohep.2024.101571_bib0014","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7109","key":"10.1016\/j.aohep.2024.101571_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.aohep.2024.101571_bib0016","doi-asserted-by":"crossref","first-page":"e00306","DOI":"10.14309\/ctg.0000000000000306","article-title":"No effect in alcoholic hepatitis of gut-selective, broad-spectrum antibiotics on bacterial translocation or hepatic and systemic inflammation","volume":"12","author":"St\u00f8y","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"10.1016\/j.aohep.2024.101571_bib0017","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00535-017-1336-z","article-title":"Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study","volume":"52","author":"Parker","year":"2017","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101571_bib0018","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/jgh.12070","article-title":"Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis","volume":"28","author":"Vlachogiannakos","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101571_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264278","article-title":"The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: a randomized clinical trial","volume":"17","author":"Kimer","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.aohep.2024.101571_bib0020","first-page":"1367","article-title":"Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease\u2013a double-blind, placebo-controlled trial","volume":"21","author":"Bode","year":"1997","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.aohep.2024.101571_bib0021","doi-asserted-by":"crossref","first-page":"607","DOI":"10.14309\/ajg.0000000000001611","article-title":"Primary norfloxacin prophylaxis for apasl-defined acute-on-chronic liver failure: a placebo-controlled double-blind randomized trial","volume":"117","author":"Kulkarni","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101571_bib0022","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2024.101571_bib0023","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12879-023-08557-6","article-title":"Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis","volume":"23","author":"Song","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.aohep.2024.101571_bib0024","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(98)80061-5","article-title":"Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial","volume":"29","author":"Grang\u00e9","year":"1998","journal-title":"J Hepatol"},{"issue":"11\u201312","key":"10.1016\/j.aohep.2024.101571_bib0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/apt.14361","article-title":"Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis","volume":"46","author":"Goel","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.aohep.2024.101571_bib0026","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.cgh.2016.05.040","article-title":"Use of antibiotics among patients with cirrhosis and upper gastrointestinal bleeding is associated with reduced mortality","volume":"14","author":"Moon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101571_bib0027","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2036.2009.03958.x","article-title":"Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis","volume":"29","author":"Vlachogiannakos","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.aohep.2024.101571_bib0028","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101571_bib0029","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101571_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/236963","article-title":"Rifaximin versus nonabsorbable disaccharides for the treatment of hepatic encephalopathy: a meta-analysis","volume":"2013","author":"Wu","year":"2013","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"10.1016\/j.aohep.2024.101571_bib0031","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/aogs.13309","article-title":"A simplified guide to randomized controlled trials","volume":"97","author":"Bhide","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.aohep.2024.101571_bib0032","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.aohep.2024.101571_bib0033","article-title":"Antibiotics in chronic liver disease and their effects on gut microbiota","volume":"12","author":"Mendez-Sanchez","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.aohep.2024.101571_bib0034","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101571_bib0035","article-title":"Antibiotics and liver cirrhosis: what the physicians need to know","volume":"11","author":"Zoratti","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.aohep.2024.101571_bib0036","article-title":"Rifaximin modulates the gut microbiota to prevent hepatic encephalopathy in liver cirrhosis without impacting the resistome","volume":"11","author":"Yu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"10.1016\/j.aohep.2024.101571_bib0037","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/MEG.0000000000000724","article-title":"Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis","volume":"28","author":"Elfert","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2024.101571_bib0038","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5414\/CP203773","article-title":"Multiple-dose pharmacokinetics and safety of amoxicillin\/clavulanate in healthy elderly subjects","volume":"58","author":"Lee","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.aohep.2024.101571_bib0039","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101571_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med Res Methodol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124003545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:32:27Z","timestamp":1777782747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124003545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124003545"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101571","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of prophylactic antibiotics in the adjuvant treatment of alcohol-related liver disease (ALD): A systematic review and meta-analysisProphylactic antibiotics in ALD","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101571"}}